Ratings by Argus (Jasper Hellweg)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/1/2026 | Regeneron Pharma | REGN | Upgrade | Buy (Hold) |
758.27 (790.74) |
4.28% | Details | |
| 8/11/2026 | Merck | MRK | Maintain | Buy (N/A) |
|
Details | ||
| 5/28/2026 | Virtus Investment Partners | VRTS | Maintain | Buy (N/A) |
|
Details | ||
| 5/27/2026 | Zoetis Inc. | ZTS | Downgrade | Hold (Buy) |
80.23 (79.38) |
-1.06% | Details | |
| 4/6/2026 | Roche | RHHBY | Upgrade | Buy (Hold) |
49.85 (57.14) |
14.62% | Details | |
| 3/27/2026 | Perrigo Co. | PRGO | Maintain | Hold (N/A) |
|
Details | ||
| 3/26/2026 | Illumina | ILMN | Maintain | Buy (N/A) |
|
Details | ||
| 3/19/2026 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/11/2026 | Novartis | NVS | Upgrade | Buy (Hold) |
161.59 (150.62) |
-6.79% | Details | |
| 11/19/2025 | Elanco Animal Health | ELAN | Maintain | Buy (Hold) |
|
Details | ||
| 10/31/2025 | Baxter International | BAX | Downgrade | Hold (Buy) |
19.16 (25.28) |
31.94% | Details | |
| 6/30/2025 | Regeneron Pharma | REGN | Downgrade | Hold (Buy) |
521.00 (758.27) |
45.54% | Details | |
| 4/4/2025 | Biogen | BIIB | Downgrade | Hold (Buy) |
130.71 (232.65) |
77.99% | Details | |
| 2/24/2025 | Baxter International | BAX | Upgrade | Buy (Hold) |
33.82 (19.16) |
-43.35% | Details | |
| 2/11/2025 | Equifax | EFX | Downgrade | Hold (Buy) |
252.90 (161.25) |
-36.24% | Details | |
| 1/14/2025 | Perrigo Co. | PRGO | Downgrade | Hold (Buy) |
24.34 (16.63) |
-31.68% | Details | |
| 10/31/2024 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 8/28/2024 | Illumina | ILMN | Upgrade | Buy (Hold) |
130.90 (262.54) |
100.57% | Details | |
| 7/26/2024 | Sanofi-Aventis | SNY | Maintain | Buy (N/A) |
|
Details | ||
| 7/10/2024 | Teva Pharma | TEVA | Upgrade | Buy (Hold) |
15.81 (41.50) |
162.49% | Details | |
| 7/8/2024 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 6/25/2024 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2024 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 4/29/2024 | Integer Holding | ITGR | Maintain | Buy (N/A) |
|
Details | ||
| 4/3/2024 | Sanofi-Aventis | SNY | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2024 | IQVIA Holdings | IQV | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2024 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 12/4/2023 | HCA Holdings | HCA | Maintain | Buy (N/A) |
|
Details | ||
| 11/14/2023 | Vertex | VRTX | Maintain | (N/A) |
|
Details | ||
| 9/19/2023 | Zoetis Inc. | ZTS | Maintain | Buy (N/A) |
|
Details | ||
| 7/6/2023 | Veradigm Inc | MDRX | Downgrade | Hold (Buy) |
12.70 (5.00) |
-60.63% | Details | |
| 4/17/2023 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 3/29/2023 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/22/2023 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2023 | HCA Holdings | HCA | Maintain | Buy (N/A) |
|
Details | ||
| 1/25/2023 | Illumina | ILMN | Downgrade | Hold (Buy) |
215.15 (262.54) |
22.03% | Details | |
| 1/18/2023 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 1/11/2023 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 12/7/2022 | Allscripts | MDRX | Upgrade | Buy (Hold) |
18.50 (5.00) |
-72.97% | Details | |
| 11/17/2022 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2022 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 10/24/2022 | Equifax | EFX | Maintain | Buy (N/A) |
|
Details | ||
| 9/22/2022 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 9/14/2022 | Perrigo Co. | PRGO | Upgrade | Buy (Hold) |
39.33 (16.63) |
-57.72% | Details | |
| 8/18/2022 | IQVIA Holdings | IQV | Maintain | Buy (N/A) |
|
Details | ||
| 8/17/2022 | Quest Diagnostics | DGX | Maintain | Buy (N/A) |
|
Details | ||
| 6/30/2022 | Illumina | ILMN | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2022 | Zoetis Inc. | ZTS | Maintain | Buy (N/A) |
|
Details | ||
| 6/13/2022 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/10/2022 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 5/31/2022 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 4/11/2022 | Cerner | CERN | Downgrade | Hold (Buy) |
93.40 (94.92) |
1.63% | Details | |
| 2/7/2022 | Anthem | ANTM | Maintain | Buy (N/A) |
|
Details | ||
| 1/27/2022 | Teva Pharma | TEVA | Downgrade | Hold (Buy) |
8.44 (41.50) |
391.71% | Details | |
| 10/25/2021 | Anthem | ANTM | Maintain | Buy (N/A) |
|
Details | ||
| 10/22/2021 | Equifax | EFX | Upgrade | Buy (Hold) |
255.47 (161.25) |
-36.88% | Details | |
| 9/10/2021 | IQVIA Holdings | IQV | Maintain | Buy (N/A) |
|
Details | ||
| 8/2/2021 | HCA Holdings | HCA | Maintain | Buy (N/A) |
|
Details | ||
| 7/26/2021 | Teva Pharma | TEVA | Maintain | Buy (N/A) |
|
Details | ||
| 7/14/2021 | United Therapeutics Corp. | UTHR | Upgrade | Buy (Hold) |
183.55 (533.12) |
190.45% | Details | |
| 6/9/2021 | Integer Holding | ITGR | Upgrade | Buy (Hold) |
87.17 (73.89) |
-15.23% | Details | |
| 5/28/2021 | Zoetis Inc. | ZTS | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2021 | IQVIA Holdings | IQV | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2021 | Anthem | ANTM | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2021 | Emergent BioSolutions | EBS | Downgrade | Hold (Buy) |
59.10 (6.38) |
-89.2% | Details | |
| 4/26/2021 | Teva Pharma | TEVA | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2021 | Allscripts | MDRX | Downgrade | Hold (Buy) |
15.57 (5.00) |
-67.89% | Details | |
| 2/8/2021 | HCA Holdings | HCA | Maintain | Buy (N/A) |
|
Details | ||
| 1/13/2021 | Anthem | ANTM | Maintain | Buy (N/A) |
|
Details | ||
| 12/29/2020 | Cerner | CERN | Maintain | Buy (N/A) |
|
Details | ||
| 12/9/2020 | Elanco Animal Health | ELAN | Downgrade | Hold (Buy) |
29.79 (23.55) |
-20.95% | Details | |
| 12/1/2020 | Illumina | ILMN | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2020 | Allscripts | MDRX | Upgrade | Buy (Hold) |
12.11 (5.00) |
-58.71% | Details | |
| 10/21/2020 | Quest Diagnostics | DGX | Upgrade | Buy (Hold) |
123.32 (235.00) |
90.56% | Details | |
| 10/7/2020 | Integer Holding | ITGR | Downgrade | Hold (Buy) |
60.53 (126.70) |
109.32% | Details | |
| 9/4/2020 | Baxter International | BAX | Downgrade | Hold (Buy) |
83.47 (25.28) |
-69.71% | Details | |
| 8/18/2020 | Elanco Animal Health | ELAN | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2020 | Emergent BioSolutions | EBS | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2020 | HCA Holdings | HCA | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2020 | IQVIA Holdings | IQV | Maintain | Buy (N/A) |
|
Details | ||
| 6/12/2020 | Fiserv | FISV | Maintain | Buy (N/A) |
|
Details | ||
| 5/21/2020 | Illumina | ILMN | Maintain | Buy (N/A) |
|
Details | ||
| 5/15/2020 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2020 | Emergent BioSolutions | EBS | Maintain | Buy (N/A) |
|
Details | ||
| 4/17/2020 | Perrigo Co. | PRGO | Downgrade | Hold (Buy) |
50.84 (16.63) |
-67.29% | Details | |
| 4/9/2020 | Integer Holding | ITGR | Maintain | Buy (N/A) |
|
Details | ||
| 4/6/2020 | Equifax | EFX | Downgrade | Hold (Buy) |
106.62 (255.47) |
139.61% | Details | |
| 3/24/2020 | Ligand Pharma | LGND | Downgrade | Hold (Buy) |
70.54 (295.54) |
318.97% | Details | |
| 3/12/2020 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2020 | IQVIA Holdings | IQV | Maintain | Buy (N/A) |
|
Details | ||
| 2/18/2020 | Teva Pharma | TEVA | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2020 | Fiserv | FISV | Maintain | Buy (N/A) |
|
Details | ||
| 2/11/2020 | Regeneron Pharma | REGN | Upgrade | Buy (Hold) |
386.21 (790.74) |
104.74% | Details | |
| 1/30/2020 | HCA Holdings | HCA | Maintain | Buy (N/A) |
|
Details | ||
| 1/29/2020 | Mylan | MYL | Maintain | Buy (N/A) |
|
Details | ||
| 1/27/2020 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 1/17/2020 | Equifax | EFX | Upgrade | Buy (Hold) |
151.02 (161.25) |
6.77% | Details | |
| 1/9/2020 | Integer Holding | ITGR | Maintain | Buy (N/A) |
|
Details | ||
| 9/25/2019 | Illumina | ILMN | Maintain | Buy (N/A) |
|
Details | ||
| 9/4/2019 | Zoetis Inc. | ZTS | Maintain | Buy (N/A) |
|
Details | ||
| 8/22/2019 | Cerner | CERN | Upgrade | Buy (Hold) |
71.78 (94.92) |
32.24% | Details | |
| 7/5/2019 | Teva Pharma | TEVA | Upgrade | Buy (Hold) |
9.60 (41.50) |
332.29% | Details | |
| 6/10/2019 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 1/31/2019 | Quest Diagnostics | DGX | Downgrade | Hold (Buy) |
86.92 (235.00) |
170.36% | Details | |
| 11/14/2018 | Allscripts | MDRX | Downgrade | Hold (Buy) |
9.90 (5.00) |
-49.49% | Details | |
| 11/13/2018 | Zoetis Inc. | ZTS | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2018 | Emergent BioSolutions | EBS | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2018 | Integer Holding | ITGR | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2018 | HCA Holdings | HCA | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2018 | Baxter International | BAX | Upgrade | Buy (Hold) |
62.51 (25.28) |
-59.56% | Details | |
| 10/30/2018 | Laboratory Corporation of America | LH | Downgrade | Hold (Buy) |
154.53 (317.95) |
105.75% | Details | |
| 10/24/2018 | Quest Diagnostics | DGX | Maintain | Buy (N/A) |
|
Details | ||
| 10/3/2018 | Allscripts | MDRX | Maintain | Buy (N/A) |
|
Details | ||
| 9/19/2018 | Fiserv | FISV | Maintain | Buy (N/A) |
|
Details | ||
| 9/14/2018 | Quest Diagnostics | DGX | Maintain | Buy (N/A) |
|
Details | ||
| 9/11/2018 | Emergent BioSolutions | EBS | Maintain | Buy (N/A) |
|
Details | ||
| 9/11/2018 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2018 | Tesaro | TSRO | Downgrade | Hold (Buy) |
27.16 (74.96) |
175.99% | Details | |
| 8/14/2018 | Zoetis Inc. | ZTS | Maintain | Buy (N/A) |
|
Details |
